Gender | |
Male | 21 (53.8%) |
Female | 18 (46.2%) |
Age (years) | 53.8 ± 24.2 |
Cardiac MRI indication | |
Ischaemic cardiomyopathy | 20 (51.3%) |
Myocardial viability | 19 |
Myocardial perfusion | 1 |
Congenital heart disease | 13 (33.3%) |
Right ventricle after Fallot surgery | 6 |
Systemic ventricle after Mustard surgery | 3 |
Systemic ventricle in ccTGA patients | 2 |
Heterotaxia syndrome with single atria | 2 |
Evaluation of the right ventricle | 4 (10.3%) |
Arrhythmogenic right ventricular cardiomyopathy | 2 |
Severe tricuspid regurgitation | 2 |
Other | 2 (5.1%) |
Pulmonary vein stenosis after AF ablation | 1 |
Cardiac amyloidosis | 1 |
Pacing mode | |
Pacemaker | |
VVI | 14 (35.9%) |
VDD | 6 (15.4%) |
DDD | 11 (28.2%) |
ICD | |
VVEV | 2 (5.1%) |
VVED | 2 (5.1%) |
DDED | 4 (10.3%) |
Manufacturer | |
Medtronic® | 12 (30.8%) |
Vitatron® | 4 (10.3%) |
Biotronik® | 5 (12.8%) |
Sorin® | 4 (10.3%) |
St. Jude Medical® | 6 (15.4%) |
Boston Scientific® | 8 (20.5%) |
Gender | |
Male | 21 (53.8%) |
Female | 18 (46.2%) |
Age (years) | 53.8 ± 24.2 |
Cardiac MRI indication | |
Ischaemic cardiomyopathy | 20 (51.3%) |
Myocardial viability | 19 |
Myocardial perfusion | 1 |
Congenital heart disease | 13 (33.3%) |
Right ventricle after Fallot surgery | 6 |
Systemic ventricle after Mustard surgery | 3 |
Systemic ventricle in ccTGA patients | 2 |
Heterotaxia syndrome with single atria | 2 |
Evaluation of the right ventricle | 4 (10.3%) |
Arrhythmogenic right ventricular cardiomyopathy | 2 |
Severe tricuspid regurgitation | 2 |
Other | 2 (5.1%) |
Pulmonary vein stenosis after AF ablation | 1 |
Cardiac amyloidosis | 1 |
Pacing mode | |
Pacemaker | |
VVI | 14 (35.9%) |
VDD | 6 (15.4%) |
DDD | 11 (28.2%) |
ICD | |
VVEV | 2 (5.1%) |
VVED | 2 (5.1%) |
DDED | 4 (10.3%) |
Manufacturer | |
Medtronic® | 12 (30.8%) |
Vitatron® | 4 (10.3%) |
Biotronik® | 5 (12.8%) |
Sorin® | 4 (10.3%) |
St. Jude Medical® | 6 (15.4%) |
Boston Scientific® | 8 (20.5%) |
MRI, magnetic resonance imaging; ccTGA, congenital corrected transposition of the great arteries; AF, atrial fibrillation; ICD, implantable cardioverter defibrillator.
Gender | |
Male | 21 (53.8%) |
Female | 18 (46.2%) |
Age (years) | 53.8 ± 24.2 |
Cardiac MRI indication | |
Ischaemic cardiomyopathy | 20 (51.3%) |
Myocardial viability | 19 |
Myocardial perfusion | 1 |
Congenital heart disease | 13 (33.3%) |
Right ventricle after Fallot surgery | 6 |
Systemic ventricle after Mustard surgery | 3 |
Systemic ventricle in ccTGA patients | 2 |
Heterotaxia syndrome with single atria | 2 |
Evaluation of the right ventricle | 4 (10.3%) |
Arrhythmogenic right ventricular cardiomyopathy | 2 |
Severe tricuspid regurgitation | 2 |
Other | 2 (5.1%) |
Pulmonary vein stenosis after AF ablation | 1 |
Cardiac amyloidosis | 1 |
Pacing mode | |
Pacemaker | |
VVI | 14 (35.9%) |
VDD | 6 (15.4%) |
DDD | 11 (28.2%) |
ICD | |
VVEV | 2 (5.1%) |
VVED | 2 (5.1%) |
DDED | 4 (10.3%) |
Manufacturer | |
Medtronic® | 12 (30.8%) |
Vitatron® | 4 (10.3%) |
Biotronik® | 5 (12.8%) |
Sorin® | 4 (10.3%) |
St. Jude Medical® | 6 (15.4%) |
Boston Scientific® | 8 (20.5%) |
Gender | |
Male | 21 (53.8%) |
Female | 18 (46.2%) |
Age (years) | 53.8 ± 24.2 |
Cardiac MRI indication | |
Ischaemic cardiomyopathy | 20 (51.3%) |
Myocardial viability | 19 |
Myocardial perfusion | 1 |
Congenital heart disease | 13 (33.3%) |
Right ventricle after Fallot surgery | 6 |
Systemic ventricle after Mustard surgery | 3 |
Systemic ventricle in ccTGA patients | 2 |
Heterotaxia syndrome with single atria | 2 |
Evaluation of the right ventricle | 4 (10.3%) |
Arrhythmogenic right ventricular cardiomyopathy | 2 |
Severe tricuspid regurgitation | 2 |
Other | 2 (5.1%) |
Pulmonary vein stenosis after AF ablation | 1 |
Cardiac amyloidosis | 1 |
Pacing mode | |
Pacemaker | |
VVI | 14 (35.9%) |
VDD | 6 (15.4%) |
DDD | 11 (28.2%) |
ICD | |
VVEV | 2 (5.1%) |
VVED | 2 (5.1%) |
DDED | 4 (10.3%) |
Manufacturer | |
Medtronic® | 12 (30.8%) |
Vitatron® | 4 (10.3%) |
Biotronik® | 5 (12.8%) |
Sorin® | 4 (10.3%) |
St. Jude Medical® | 6 (15.4%) |
Boston Scientific® | 8 (20.5%) |
MRI, magnetic resonance imaging; ccTGA, congenital corrected transposition of the great arteries; AF, atrial fibrillation; ICD, implantable cardioverter defibrillator.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.